Need to find a specific expert or member of a research group or division? Just search by role, division, name or browse our researchers A-Z.

Scientists have developed a tool that can predict how bowel cancer adapts to treatment – helping researchers to design new personalised drugs that will keep patients living well for longer. A team ...

Thousands of patients with a common type of blood cancer could benefit from a new drug combination, while others could see their disease kept at bay for longer. Research published in the journal Blood ...

Scientists have discovered clues which may explain why some treatments stop working for people with bowel cancer – causing around 16,800 deaths in the UK every year. The study, led by researchers at ...

Dr Stephen John Sammut, a clinician scientist at The Institute of Cancer Research, London, has been awarded one of the eight 2025 research prizes from the Lister Institute of Preventive Medicine.

In this special summer edition of Search, we take an in depth look at the work our scientists are doing in bringing new treatments to people with cancer, who are at the heart of everything we do. You ...

The study found that cancer cells can develop a “memory”, through switching on and off certain processes in the cell, known as “epigenetic changes”. Cells can “remember” the form and appearance they ...

In this special summer edition of Search, we take an in depth look at the work our scientists are doing in bringing new treatments to people with cancer, who are at the heart of everything we do. You ...

Tazemetostat targets EZH2 – an enzyme that is overexpressed and hyperactive in a number of cancers, including B-cell lymphoma, melanoma and prostate cancer. EZH2 inhibitors on their own have had mixed ...

Dr Stephen John Sammut, a clinician scientist at The Institute of Cancer Research, London, has been awarded one of the eight 2025 research prizes from the Lister Institute of Preventive Medicine.